Drug intelligence / Profile preview

menaquinone-9

Development stage
Preclinical
Modality
Small Molecules
Administration
Oral
01

Overview

Menaquinone-9 (MK-9) is a long-chain vitamer of Vitamin K2, characterized by a side chain containing nine isoprene units. It is primarily synthesized by various bacterial species, including those found in the human intestinal microbiota and fermented dairy products such as certain types of cheese. Like other menaquinones, MK-9 serves as an essential lipid-soluble cofactor for the enzyme gamma-glutamyl carboxylase (GGCX). This enzyme facilitates the post-translational carboxylation of glutamate residues in vitamin K-dependent proteins (VKDPs), a process necessary for their biological activation. Key VKDPs activated by MK-9 include coagulation factors in the liver, osteocalcin in bone tissue, and matrix Gla protein (MGP) in the vascular system. Due to its longer prenyl side chain, MK-9 exhibits a significantly longer circulatory half-life compared to the short-chain MK-4, allowing for more sustained tissue distribution and potential long-term benefits for skeletal and cardiovascular health by promoting bone mineralization and inhibiting arterial calcification.

Other names
Vitamin K2(45)2-methyl-3-[(2E,6E,10E,14E,18E,22E,26E,30E)-3,7,11,15,19,23,27,31,35-nonamethylhexatriaconta-2,6,10,14,18,22,26,30,34-nonaenyl]naphthalene-1,4-dione2-methyl-3-all-trans-farnesylgeranylgeranyl-1,4-naphthoquinone
02

Targets

GGCX (Vitamin K-dependent gamma-glutamyl carboxylase)

Beyond the preview

Go deeper on menaquinone-9.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on menaquinone-9.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call